Cargando…
Severe Acute Thrombocytopenia After Treatment with Tirofiban: A Case Series Approach
Glycoprotein IIb/IIIa inhibitors are an adjuvant therapy for the treatment of patients with acute coronary syndromes. The main adverse reactions are bleeding and thrombocytopenia in 1–2% of cases. A 66-year-old woman arrived at the emergency department with ST-elevation MI. The catheterisation lab w...
Autores principales: | Jiménez-Rodríguez, Gian-Manuel, Carmona-Levario, Patricia, Ayón-Martínez, José-Alberto, Gasecka, Aleksandra, Juárez-Orozco, Luis Eduardo, Reyes-Ortega, Antonio, Espinosa-González, Patricia, Altamirano-Solorzano, Gyna Alejandra, Eid-Lidt, Guering |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311402/ https://www.ncbi.nlm.nih.gov/pubmed/37398876 http://dx.doi.org/10.15420/icr.2022.23 |
Ejemplares similares
-
Tirofiban-induced thrombocytopenia
por: Wang, Jun, et al.
Publicado: (2023) -
Severe thrombocytopenia following tirofiban infusion
por: Panduranga, Prashanth, et al.
Publicado: (2011) -
Tirofiban-Induced Thrombocytopenia Occurring with Crohn's Disease
por: Ibrahim, Toni, et al.
Publicado: (2016) -
Tirofiban Induced Thrombocytopenia: A Rare but Severe Adverse Effect
por: Rawala, Muhammad Shabbir, et al.
Publicado: (2020) -
Case report: reuse of tirofiban leads to very severe thrombocytopenia
por: Li, Yuqing, et al.
Publicado: (2023)